Medicine recalls
|
|
The United States: FDA announces Standard Homeopathic Company`s nationwide voluntary recall of Hyland`s teething tablets |
|
The U.S. Food and Drug Administration (FDA) is alerting consumers of a nationwide voluntary recall of all lots of Hyland`s Baby Teething Tablets and Hyland`s Baby Nighttime Teething Tablets by the manufacturer, Standard Homeopathic Company, which is located in Los Angeles. On April 10, the company received FDA`s formal recall request and agreed to conduct a recall.
On January 27, 2017, FDA announced its laboratory analysis had found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets including Hyland`s, sometimes far exceeding the amount claimed on the label. In light of these findings and prior to the announcement, FDA contacted Standard Homeopathic Company on January 25 regarding a recall of its homeopathic teething tablet products labeled as containing belladonna, in order to protect consumers from inconsistent levels of belladonna.
Standard Homeopathic Company is notifying its distributors and retailers by mail and is arranging for the return of all recalled products. Consumers should contact their physician or healthcare provider if they believe they have experienced any problems that may be related to taking or using this drug product. FDA reminds consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/DrugSafety/ucm552924.htm
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Tuesday, April 18, 2017
Issued at HKT 15:00
|
|
|